Cys-LT7

• Description :

  Cys-LT7 is a Cys-modified analog of LT7 peptide. LT7 (HAIYPRH) is a TfR homing peptide with binding site for TfR distinct from that of Tf. Cys-LT7 can be used to construct TfR-targeted drug delivery systems[1].

• UNSPSC :

  12352209

• Target :

  Transferrin Receptor

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Purity :

  99.90

• Smiles :

  O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CC=C(C=C2)O)C(N3[C@@H](CCC3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CNC=N4)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CS)N

• Molecular Formula :

  C44H65N15O10S

• Molecular Weight :

  996.15

• References & Citations :

  [1]Yu J, et al. New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity. Molecules. 2024 Apr 12;29 (8) :1758.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [1254540-73-2]